The Effect of High Knowledge on Diabetes Type 2 and Strong Belief in Medicine with Non-Adherence of Anti Diabetic Medication: A Meta-Analysis

Sri Iswahyuni, Herbasuki Herbasuki, Sri Sayekti Heni Sunaryanti, Joko Tri Atmojo, Rejo Rejo, Aris Widiyanto
{"title":"The Effect of High Knowledge on Diabetes Type 2 and Strong Belief in Medicine with Non-Adherence of Anti Diabetic Medication: A Meta-Analysis","authors":"Sri Iswahyuni, Herbasuki Herbasuki, Sri Sayekti Heni Sunaryanti, Joko Tri Atmojo, Rejo Rejo, Aris Widiyanto","doi":"10.26911/theijmed.2022.07.02.04","DOIUrl":null,"url":null,"abstract":"Background: By 2045, the number of people with diabetes mellitus (DM) was expected to increase from 424.9 million in 2017. Healthcare professionals have had a difficult time managing diabetes because of nonadherence to therapy. Additionally, the efforts made to clarify and enhance patient adherence to their medication are not always successful. This study investigated the factors such as high knowledge on diabetes type 2 and strong belief in medicine that lead to medication non-adherence in adults . Subjects and Method: This article was a systematic review and meta-analysis study conducted by searching for articles from online databases such as EBSCO, ProQuest, and PubMed. Popula-tions: adults with diabetes mellitus; Intervention: a strong belief in anti-diabetic medication and high knowledge of diabetes mellitus; Comparison: a weak belief or none in anti-diabetic medication and little knowledge of diabetes mellitus; Outcome: non-adherence of anti-diabetic medication. The independen variables is strong belief and high knowledge, the dependen variable is nonadherence to anti-diabetic medication. The inclusion criteria for this study were full articles using a cross-sectional study, with the publication year until 2022. We conduct the analysis using RevMan 5.3 software. Results: A total of 6 articles reviewed in the meta-analysis (consisted 4 articles in each variables), from countries: Ethiopia, Australia, Uganda, Iran, Palestine and China, showed that respondents with strong belief in anti-diabetic medicines (aOR= 0.66; 95% CI= 0.48 to 0.90; p= 0.008) and high knowledge of diabetes mellitus (aOR= 0.85; 95% CI= 0.79 to 0.93; p= 0.0005) had lower level of non-adherence to anti-diabetic medication. Conclusion: A strong belief in anti-diabetic medicines and high knowledge of diabetes mellitus can lower non-adherence to anti-diabetic medication.","PeriodicalId":13354,"journal":{"name":"IJAAM (Indonesian Journal of Anti-Aging Medicine)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJAAM (Indonesian Journal of Anti-Aging Medicine)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26911/theijmed.2022.07.02.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: By 2045, the number of people with diabetes mellitus (DM) was expected to increase from 424.9 million in 2017. Healthcare professionals have had a difficult time managing diabetes because of nonadherence to therapy. Additionally, the efforts made to clarify and enhance patient adherence to their medication are not always successful. This study investigated the factors such as high knowledge on diabetes type 2 and strong belief in medicine that lead to medication non-adherence in adults . Subjects and Method: This article was a systematic review and meta-analysis study conducted by searching for articles from online databases such as EBSCO, ProQuest, and PubMed. Popula-tions: adults with diabetes mellitus; Intervention: a strong belief in anti-diabetic medication and high knowledge of diabetes mellitus; Comparison: a weak belief or none in anti-diabetic medication and little knowledge of diabetes mellitus; Outcome: non-adherence of anti-diabetic medication. The independen variables is strong belief and high knowledge, the dependen variable is nonadherence to anti-diabetic medication. The inclusion criteria for this study were full articles using a cross-sectional study, with the publication year until 2022. We conduct the analysis using RevMan 5.3 software. Results: A total of 6 articles reviewed in the meta-analysis (consisted 4 articles in each variables), from countries: Ethiopia, Australia, Uganda, Iran, Palestine and China, showed that respondents with strong belief in anti-diabetic medicines (aOR= 0.66; 95% CI= 0.48 to 0.90; p= 0.008) and high knowledge of diabetes mellitus (aOR= 0.85; 95% CI= 0.79 to 0.93; p= 0.0005) had lower level of non-adherence to anti-diabetic medication. Conclusion: A strong belief in anti-diabetic medicines and high knowledge of diabetes mellitus can lower non-adherence to anti-diabetic medication.
高知识对2型糖尿病患者抗糖尿病药物依从性的影响:一项荟萃分析
背景:到2045年,糖尿病(DM)患者人数预计将从2017年的4.249亿人增加。由于不坚持治疗,医疗保健专业人员很难管理糖尿病。此外,澄清和加强患者对药物依从性的努力并不总是成功的。本研究调查了导致成人用药不依从的因素,如对2型糖尿病的高知识和对医学的强烈信念。研究对象和方法:本文是一项系统综述和荟萃分析研究,通过搜索EBSCO、ProQuest和PubMed等在线数据库中的文章进行。人群:患有糖尿病的成年人;干预:对糖尿病药物治疗有坚定的信念,对糖尿病有较高的认识;对比:对降糖药物的信念淡薄或不认识,对糖尿病的认识少;结果:抗糖尿病药物的不依从性。自变量为信念强、知识高,因变量为抗糖尿病药物不依从性。本研究的纳入标准是采用横断面研究的完整文章,出版年份至2022年。我们使用RevMan 5.3软件进行分析。结果:meta分析共纳入6篇文章(每个变量4篇),分别来自埃塞俄比亚、澳大利亚、乌干达、伊朗、巴勒斯坦和中国,结果显示,对抗糖尿病药物有强烈信念的受访者(aOR= 0.66;95% CI= 0.48 ~ 0.90;p= 0.008)、糖尿病知晓率高(aOR= 0.85;95% CI= 0.79 ~ 0.93;P = 0.0005)患者抗糖尿病药物依从性较低。结论:对降糖药物有较强的信念,对糖尿病有较高的认识,可降低降糖药物依从性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信